0.58
-1.2451(-68.04%)
Currency In USD
| Previous Close | 1.83 |
| Open | 0.67 |
| Day High | 0.68 |
| Day Low | 0.56 |
| 52-Week High | 3.03 |
| 52-Week Low | 0.56 |
| Volume | 87.51M |
| Average Volume | 3.38M |
| Market Cap | 42.23M |
| PE | -0.25 |
| EPS | -2.32 |
| Moving Average 50 Days | 1.96 |
| Moving Average 200 Days | 1.57 |
| Change | -1.25 |
If you invested $1000 in Fractyl Health, Inc. Common Stock (GUTS) since IPO date, it would be worth $45.42 as of January 29, 2026 at a share price of $0.584. Whereas If you bought $1000 worth of Fractyl Health, Inc. Common Stock (GUTS) shares 1 year ago, it would be worth $288.91 as of January 29, 2026 at a share price of $0.584.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Fractyl Health Announces Compelling 6-Month Randomized REMAIN-1 Midpoint Data Showing Durable Weight Maintenance with Revita® After GLP-1 Discontinuation
GlobeNewswire Inc.
12 hours ago
Revita-treated patients experienced sustained weight maintenance, improved cardiometabolic profile, and reduced food cravings at 6 months compared with sham, with continued excellent safety and tolerability Patients with above median GLP-1-associated
Fractyl Health Appoints Lara Smith Weber as Chief Financial Officer to Support Commercial-Stage Preparedness
GlobeNewswire Inc.
Jan 06, 2026 12:00 PM GMT
BURLINGTON, Mass., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company” or “Fractyl”), a metabolic therapeutics company focused on pattern-breaking approaches that treat root causes of obesity and type 2 diabetes (“T
Fractyl Health Enters a Catalyst-Rich 2026 Positioned to Define the Post-GLP-1 Weight Maintenance Therapeutic Category
GlobeNewswire Inc.
Jan 05, 2026 12:00 PM GMT
Randomized 6-month data from the REMAIN-1 Midpoint Cohort expected in late January 2026 Topline 6-month data from the REMAIN-1 Pivotal Cohort and potential PMA submission expected in H2 2026 Approximately $85.6 million in cash and cash equivalents on